Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea: Changes in Microfilaremia, Filarial Antigen, and Bm14 Antibody after Cessation | Zendy

Daniel J. Tisch | Zendy; F E Hazlett | Zendy; Michael P. Alpers | Zendy; James W. Kazura | Zendy; Will Kastens | Zendy; Benson Kiniboro | Zendy; Moses J. Bockarie | Zendy; Nandao Tarongka | Zendy; Zachary Dimber | Zendy

Open Access

Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea: Changes in Microfilaremia, Filarial Antigen, and Bm14 Antibody after Cessation

Author(s) -

Daniel J. Tisch,

F E Hazlett,

Michael P. Alpers,

James W. Kazura,

Will Kastens,

Benson Kiniboro,

Moses J. Bockarie,

Nandao Tarongka,

Zachary Dimber

Publication year - 2008

Publication title -

american journal of tropical medicine and hygiene

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.015

H-Index - 151

eISSN - 1476-1645

pISSN - 0002-9637

DOI - 10.4269/ajtmh.2008.78.289

Subject(s) - lymphatic filariasis , microfilaria , wuchereria bancrofti , mass drug administration , filariasis , diethylcarbamazine , medicine , immunology , antibody , brugia malayi , antigen , helminthiasis , transmission (telecommunications) , physiology , helminths , population , environmental health , electrical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research